Percutaneous transluminal coronary angioplasty: an added modality for the treatment of the patient with coronary heart disease

Iannone, L.A.; Brown, T.M.; Phillips, S.J.; Wickemeyer, W.J.; Zeff, R.H.; Wheeler, W.S.; Kongtahworn, C.; Rough, R.R.; Skinner, J.R.; Toon, R.S.

Cardiologia 28(7): 625-633

1983


ISSN/ISBN: 0393-1978
PMID: 6234906
Document Number: 216258
Experience with transluminal coronary angioplasty is discussed. Dilatation was attempted in 419 patients and 450 lesions. Patients' age ranged from 30-84 yr. The procedure was successful in 81.6% of cases. Complication consisted of ventricular fibrillation (1.4%), acute myocaridal infarction (4.3%) emergency bypass surgery (8.9%). Overall mortality was 1.2%: 0.07% in the laboratory or following emergency surgery, 0.05% within the 1st mo. and 0.08% beyond the 1st mo. after dilatation. The risk-benefit ratio of the procedure is equal to or better than that of coronary bypass surgery, and dilatation can be offered to elderly patients and to patients with multivessel disease.

Document emailed within 1 workday
Secure & encrypted payments